169 related articles for article (PubMed ID: 8834197)
21. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
[TBL] [Abstract][Full Text] [Related]
22. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic alterations of quinapril during repeated treatment in elderly subjects.
Sasaki M; Maeda A; Fujimura A
Eur J Clin Pharmacol; 1998 Jun; 54(4):347-9. PubMed ID: 9696962
[TBL] [Abstract][Full Text] [Related]
24. Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril.
Yuan H; Feng B; Yu Y; Chupka J; Zheng JY; Heath TG; Bond BR
J Pharmacol Exp Ther; 2009 Jul; 330(1):191-7. PubMed ID: 19349522
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and bioequivalence study of the two 20-mg quinapril hydrochloride tablet formulations in healthy Thai male volunteers.
Rojanasthien N; Nasangiam N; Kumsorn B; Roongapinun S; Jengjareon A
J Med Assoc Thai; 2008 May; 91(5):739-46. PubMed ID: 18672641
[TBL] [Abstract][Full Text] [Related]
26. Determination of the angiotensin-converting enzyme inhibitor quinapril and its metabolite quinaprilat in pharmaceuticals and urine by capillary zone electrophoresis and solid-phase extraction.
Prieto JA; Alonso RM; Jiménez RM
Electrophoresis; 2002 Jan; 23(1):102-9. PubMed ID: 11824610
[TBL] [Abstract][Full Text] [Related]
27. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.
Kaplan HR; Taylor DG; Olson SC; Andrews LK
Angiology; 1989 Apr; 40(4 Pt 2):335-50. PubMed ID: 2539761
[TBL] [Abstract][Full Text] [Related]
28. Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat).
Horvath AM; Pilon D; Caillé G; Colburn WA; Ferry JJ; Frank GJ; Lacasse Y; Olson SC
Biopharm Drug Dispos; 1990 Apr; 11(3):191-6. PubMed ID: 2328305
[TBL] [Abstract][Full Text] [Related]
29. Fertility and perinatal/postnatal studies in rats with the angiotensin-converting enzyme inhibitor, quinapril.
Dostal LA; Kim SN; Schardein JL; Anderson JA
Fundam Appl Toxicol; 1991 Nov; 17(4):684-95. PubMed ID: 1778358
[TBL] [Abstract][Full Text] [Related]
30. The clinical pharmacokinetics of quinapril.
Olson SC; Horvath AM; Michniewicz BM; Sedman AJ; Colburn WA; Welling PG
Angiology; 1989 Apr; 40(4 Pt 2):351-9. PubMed ID: 2705643
[TBL] [Abstract][Full Text] [Related]
31. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Major TC; Overhiser RW; Taylor DG; Panek RL
J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
[TBL] [Abstract][Full Text] [Related]
32. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
33. Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril.
Elliott HL; Macdonald NJ; Meredith PA; Reid JL
Clin Pharmacol Ther; 1992 Mar; 51(3):260-5. PubMed ID: 1312002
[TBL] [Abstract][Full Text] [Related]
34. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.
Padoin C; Tod M; Perret G; Petitjean O
Antimicrob Agents Chemother; 1998 Jun; 42(6):1463-9. PubMed ID: 9624495
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.
Fabris B; Chen BZ; Pupic V; Perich R; Johnston CI
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S6-13. PubMed ID: 1691409
[TBL] [Abstract][Full Text] [Related]
38. Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor.
MacDonald JR; Susick RL; Pegg DG; Dominick MA
J Cardiovasc Pharmacol; 1992 Feb; 19(2):282-9. PubMed ID: 1376798
[TBL] [Abstract][Full Text] [Related]
39. A novel HPLC assay for pentamidine: comparative effects of creatinine and inulin on GFR estimation and pentamidine renal excretion in the isolated perfused rat kidney.
Poola NR; Bhuiyan D; Ortiz S; Savant IA; Sidhom M; Taft DR; Kirschenbaum H; Kalis M
J Pharm Pharm Sci; 2002; 5(2):135-45. PubMed ID: 12207866
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.
Jacolot A; Tod M; Petitjean O
Antimicrob Agents Chemother; 1996 Apr; 40(4):979-82. PubMed ID: 8849263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
